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ABSTRACT 
PURPOSE: To evaluate KGF and human beta defensin-4 (HBD-4) levels produced by dermic fibroblasts and keratinocytes cultivated 
from burned patients’ skin samples. 
METHODS: Keratinocytes and fibroblasts of 10 patients (four major burns, four minor burns and two controls) were primarily 
cultivated according to standard methods. HBD-4 and KGF genes were analyzed by quantitative PCR. 
RESULTS: In fibroblasts, KGF gene expression was 220±80 and 33.33±6.67 (M±SD; N=4), respectively for major and minor burn 
groups. In keratinocytes, KGF gene expression was 11.2±1.9 and 3.45±0.37 (M±SD; N=4), respectively for major and minor burn 
groups. In fibroblasts, HBD-4 gene expression was 15.0±4.0 and 11.5±0.5 (M±SD; N=4), respectively for major and minor burn. In 
keratinocyte, HBD-4 gene expression was 0.0±0.0 and 13.4±4.8 (M±SD; N=4), respectively for major and minor burn. 
CONCLUSIONS: KGF expression was increased in burn patient fibroblasts compared to control group. In keratinocytes culture, KGF 
suppression is inversely proportional to burn extension; it is active and increased in major burn but decreased in minor burn. HBD-4 
expression was increased in fibroblasts and decreased in keratinocytes from all burned patients.
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Introduction
 The high incidence of infection among burn patients is a 
major concern in its clinical evolution, which is directly related to 
morbidity and mortality rates of this group. Antimicrobial peptides, 
components of innate immune response, protect the organism 
by the activation of inflammatory cells or inactivating pathogen 
action directly. Therefore, the increased expression in these 
peptides by the epithelial cells improves hosts resistance against 
microbial infection1,2 . Among the great diversity of antimicrobial 
peptides involved in the inflammatory response, we highlight here 
the defensin family. Defensins are able to permeabilize bacterial 
membranes selectively, as has been proved in the study of peptides 
Crp-4, HBD-2, HBD-3, RTD-1 e BTD-73.
HBD-4 presents a high antimicrobial activity against 
Pseudomonas aeruginosa when expressed by genetically 
modified primary epidermal keratinocytes4. HBD-3 shows strong 
bactericidal activity against Staphylococcus aureus and MRSA 
when its expression is induced in human keratinocytes and 
fibroblasts5.
HBD-2 inhibits in vitro growth of the dermatophytes 
Trichophyton rubrum, T. mentagrophytes, Microsporum canis 
e Epidermophyton floccosum, despite not as much as psoriasin, 
RNAse 7 and fluconazol6.
Studies concerning keratinocyte growth factor (KGF) 
actions in skin lead to quantitative relations between KGF 
levels and immune response antimicrobial peptides. It was 
demonstrated that RNAm codifying HBD-2 and cathelecidin-37 
quantity is increased proportionally to the KGF gene expression 
in cultured cells7,8 .
Keratinocytes cultures treated with interleukin-1-alpha 
presents high level of the antimicrobial peptides human beta-
defensin 1 and 2, IL-37 and antileukoprotease. When infected with 
Escherichia coli, Pseudomonas aeruginosa and Staphylococcus 
aureus, its antibacterial activity is significantly increased9. 
In direct contact with bacteria as Pseudomonas 
aeruginosa, KGF alone is unable to prevent their proliferation. 
However, cultured human keratinocytes that produced KGF 
or other culture supplemented with this growth factor are able 
to exuberantly inhibit bacterial proliferation. Therefore, it is 
suggested that KGF is a skin immune response modulator, possibly 
through inducing defensins production by keratinocytes10.
We infer that KGF acts indirectly, as an immune 
response modulator, as the substance itself does not present any 
effect in the microorganisms. The present study hypothesis is 
that KGF might be the trigger to some antimicrobial peptides 
production by keratinocytes, such as human beta defensins. 
Therefore, our objective is to perform a quantitative analysis 
of keratinocyte growth factor (KGF) gene expression and 
human beta-defensin-4 (HBD-4) produced by fibroblasts and 
keratinocytes, respectively, from cultured burned patients skin 
samples.
Methods
The project was approved by the Ethics Committee of 
Federal University of Sao Paulo (UNIFESP) in October 14th, 
2011 (1454/11). The present study is experimental, in vitro, using 
discarded skin from burned patients. It is observational, analytic, 
controlled and conduced in a single center. Patients included in 
this study have read and signed the Free and Clarified Contentment 
Term.
The patients recruited to this study were burn victims 
admitted in the Burns Treatment Unit, Plastic Surgery Division, 
University Hospital (UNIFESP), and the control group with 
healthy patients, non-smoking, submitted to mammoplasty in the 
Plastic Surgery Division. The culture of cells was realized, and we 
have created a cell bank with the characteristics of these patients, 
which have been previously published11. 
Inclusion, exclusion and non-inclusion criteria
Inclusion criteria for the study were patients of both 
genders, over 18 years old, for the group with major burns: having 
deep partial thickness or full thickness burns affecting between 
25% and 50% of total body area surface (TBSA) or which require 
partial skin graft in 10% TBSA. For the minor burns group, the 
criterion added was that the affected TBSA should be 5% or less, 
for deep partial thickness or full thickness burns and the need of 
partial skin graft. To the control group was included the criterion 
of not having previous diseases, not smoking, and performing 
aesthetic surgery.
Patients who had previous skin diseases or conditions 
that should interfere directly in the inflammatory process were not 
included. Exclusion criteria were the lost of the extracted material. 
The surgical procedure, fibroblasts and keratinocytes cultures, and 
total RNA extraction were reported earlier11.
Commercially available TaqMan Gene Expression 
Assay kits (Applied Biosystems, Foster City, CA) were 
used to assess HBD-4 (Hs00823638_m1) and FGF7 (KGF) 
(Hs00384281_m1). B-actin gene (Hs99999903_m1) was used 
as housekeeping gene11,12. All qPCR reactions were performed 
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on an ABI Prism 7000 Sequence Detection System (Applied 
Biosystems, Foster City, CA) using the fluorescent Taqman 
methodology (TaqMan One Step qPCR Master Mix Reagentes, 
Applied Biosytems, Foster City, CA). 100 ng of total RNA) was 
used for each qPCR reaction in a total volume of 50μL according 
to the manufacturer’s protocol. Thermal cycling conditions 
were as follow: 30s at 48ºC, 10 min at 95ºC, 40 cycles of 15s, 
denaturation at 95ºC, and 60 s annealing at 60ºC. Quantification 
Cycle (Cq) values were used as endpoint defined as the PCR cycle 
number in which the fluorescence generated by the amplification 
crosses the threshold. Each gene was submitted to an absolute 
quantification assay by means of a standard curve, produced 
by dilutions to calculate the amount of a target sequence in a 
solution. The results were expressed in the same measure units 
as the standard curve. Three replicate reactions per sample were 
run to ensure statistical significance. 
The assays were made in triplicate and the experimental 
values obtained in the study were presented by mean (M) and 
standard deviation (SD), because it is a cultured cells assay, 
where there is the homogenization of the cells lineage, with any 
stimulation differing from the culture medium. The calculation 
of the Cq were obtained as described in previous study11. The 
comparative Cq method (also known as the 2-DDqC method)13 
was used for data analysis in order to calculate relative quantities 
(RQs) of gene expression among the samples. DataAssistTM, 
software developed for quick analysis of TaqMan real-time PCR 
(Applied Biosystems, Foster City, CA), was used to confirm the 
data calculations performed in Microsoft Office Excel. Whenever 
receptor quantification exceeded 36 amplification rounds (qC), 
quantities were considered to be undetectable or very low, and 
measurements were taken as invalid. Statistical significance was 
assessed using the Student’s t-test. Statistical significance was 
defined at p<0.05.
Results
Keratinocyte growth factor (KGF) expression in 
fibroblast culture 
The gene responsible for KGF synthesis is over expressed 
in burn patients’ fibroblasts compared to the control group (Figure 
1). Apparently there is no difference between expression levels 
among the minor and major burn groups and there is only a 
tendency to significance with p=0.081. The mean of the minor and 
major burn groups were (M ± SD): 33.33 ± 6.67 (n=4) and 220 ± 
80 (n=4), respectively. 
Keratinocyte growth factor (KGF) expression in 
keratinocyte culture
In keratinocyte culture, the expression of the KGF gene 
seems to be directly proportional to burn injury extension. It is 
active and over expressed in the major burn group and under 
expressed in the minor burn group (Figure 2). There was a 
difference (p=0.019) between both groups. The mean obtained for 
minor and major burn groups were (M ± SD): 3.45 ± 0.37 (n=4) 
and 11.2 ± 1.9 (n=4), respectively.
Figure 1. KGF (FGF-7) gene expression in burned patients’ fibroblasts.
Figure 2. KGF gene expression in burned patients’ keratinocyte.
Human beta-defensin-4 (HBD-4) expression in 
fibroblast culture
HBD-4 is over expressed in burned patients’ fibroblasts 
of both minor and major groups, compared to the control (Figure 
3). No difference was shown between minor and major groups 
(p=0.43). The mean of minor and major burn were (M±SD): 11.5 
± 0.5 (n=4) and 15.0 ± 4.0 (n=4), respectively. 
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Human beta-defensin-4 (HBD-4) expression in 
keratinocyte culture
The keratinocytes cultured had the gene HBD-4 repressed 
in a directly proportional manner to the extension of the burn 
(Figure 4). In the major burn group, HDB-4 gene is active and 
over expressed compared to control, while it is no expressed in the 
minor burn group. The mean of minor and major burn were (M 
± SD): 13.4 ± 4.8 (n=4) and 0 ± 0 (non-expressed), respectively. 
in normal skin samples, without any injuries, while in situ 
hybridization has revealed an important increase in the expression 
of RNA codifying KGF only 1 day after skin damage. That increase 
is progressively proportional to the age of the damage infringed7. 
Murine beta-defensin (mBD) has been detected in normal 
skin samples taken from burn murine models, while samples 
taken from areas which were submitted to thermal injury have 
shown a large decrease in mBD concentration. Gr-1(+)CD11b(+) 
cells, capable of suppress antimicrobial peptides production by 
keratinocytes, have been isolated from the circundating tissue 
around burned site in murine models. When those cells were 
inoculated in control rats, without burn injury, antimicrobial 
peptides production around inoculation site has decreased. Both 
groups have shown increase of intradermal infection incidence by 
Pseudomonas aeruginosa16.
Similar to previously reported, our study has shown 
that occurred a significant increase in HBD-4 expression in area 
marginal to the burned skin. In detail, our results have shown that 
in the minor burn group the HBD-4 gene has its activity repressed, 
while in major burn group it is active, but hypo expressed.
The antibiotic use, although essential to the burned 
patient treatment, causes selection of multiresistant bacteria. 
Antibiotic resistant Acinetobacter baumannii, Staphylococcus 
aureus and Pseudomonas aeruginosa cultures were analyzed. All 
of them have shown sensibility to HBD-4 antimicrobial activity, 
without any relation between resistances to the most commonly 
used antibiotics and the sensibility to the human peptide17.
These data, with are consistent with results shown in this 
study, indicates that the hypo expression of HBD-4 in burn patients 
must be related to the concerning high incidence of infection and 
sepsis, especially in major burn patients. The advance of knowledge 
about the altered genes and the possibility of using drugs and 
substances able to stimulate defensin production by keratinocytes 
open a possibility to the development of new efficient treatment 
against antibiotic-resistant pathogens.
Therefore, we have the perspective to ally the knowledge 
obtained regarding KGF expression and HBD-4 expression to 
a possible drug therapy to evaluate the control of these genes 
expression in major burn patients. 
Conclusion
KGF gene expression is increased in burn patients 
fibroblasts, however, in keratinocyte culture, the expression 
of the KGF gene seems to be directly proportional to burn 
extension. HBD-4 is overexpressed in burn patients’ fibroblasts 
Figure 3. HBD-4 gene expression in burned patients’ fibroblasts.
Figure 4. HBD-4 gene expression in burned patients’ keratinocytes.
Discussion
A large amount of studies shows KGF’s importance 
as a paracrine mediator of epithelial growth. The induction 
of increased KGF expression in fibroblasts and keratinocytes 
grafted in burn models in vivo leads to significant acceleration 
of the reepithelialization process14, while KGF ablation leads to 
decreased proliferation rates, angiogenesis and VEGF mRNA 
concentration in murine models submitted to burn injury15.
Corroborating with the results obtained in the present 
study, assays utilizing RNAse has detected KGF expression 
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and in keratinocyte culture this gene was repressed in a directly 
proportional manner to the extension of the burn. 
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